Integrating untargeted and targeted LC–MS‐based metabolomics to identify the serum metabolite biomarkers for tuberculosis
Biomedical Chromatography · 2024
DOI: 10.1002/bmc.5998 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Yuping Sa und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Ningxia Medical University, 1160 Shenli Street, Yinchuan, 750004, China. Hauptthemen laut MEDLINE: Biomarkers, Metabolomics, Tuberculosis, Tandem Mass Spectrometry. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of Ningxia (2023AAC03179), Key Research and Invention Program of Ningxia (2023BEG02014), National Natural Science Foundation of China (82360684, U20A20136).
Abstract (Originalsprache)
Given the limitations of untargeted metabolomics in precise metabolite quantification, our current research employed a novel approach by integrating untargeted and targeted metabolomics utilizing ultra‐high‐performance liquid chromatography quadrupole time‐of‐flight tandem mass spectrometry (UHPLC‐QTOF‐MS/MS) to analyze the metabolic profile and potential biomarkers for tuberculosis (TB). A cohort of 36 TB patients and 36 healthy controls (HC) was enlisted to obtain serum samples. Multivariate pattern recognition and univariate statistical analysis were employed to screen and elucidate the differential metabolites, whereas dot plots and receiver operating characteristic (ROC) curves were established for the identification of potential biomarkers of TB. The results indicated a distinct differentiation between the two groups, identifying 99 metabolites associated with five primary metabolic pathways in relation to TB. Of these, 19 metabolites exhibited high levels of sensitivity and specificity, as evidenced by the area under curve values approaching 1. Following targeted quantitative analysis, three potential metabolites, namely, L‐asparagine, L‐glutamic acid, and arachidonic acid, were demonstrated excellent discriminatory ability as evidenced by the results of the ROC curve, dot plots, and random forest model. Particularly noteworthy was the enhanced diagnostic efficacy of the combination of these three metabolites compared to singular biomarkers, suggesting their potential utility as serum biomarkers for TB diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Ningxia Medical University, 1160 Shenli Street, Yinchuan, 750004, China.
ORCID-Profile: Xueqin Ma
Förderung
- Natural Science Foundation of Ningxia (2023AAC03179)
- Key Research and Invention Program of Ningxia (2023BEG02014)
- National Natural Science Foundation of China (82360684, U20A20136)
Zitieren
APA
Sa, Y., Ding, S., Zhang, Y., Wang, W., Wilson, G., Ma, F., Zhang, W., & Ma, X. (2024). Integrating untargeted and targeted LC–MS‐based metabolomics to identify the serum metabolite biomarkers for tuberculosis. Biomedical Chromatography. https://doi.org/10.1002/bmc.5998
Vancouver
Sa Y, Ding S, Zhang Y, Wang W, Wilson G, Ma F, et al. Integrating untargeted and targeted LC–MS‐based metabolomics to identify the serum metabolite biomarkers for tuberculosis. Biomedical Chromatography. 2024. doi:10.1002/bmc.5998
BibTeX
@article{Sa2024,
author = {Sa, Yuping and Ding, Shuqin and Zhang, Yue and Wang, Weibiao and Wilson, Gidion and Ma, Feng and Zhang, Weiman and Ma, Xueqin},
title = {Integrating untargeted and targeted LC–MS‐based metabolomics to identify the serum metabolite biomarkers for tuberculosis},
journal = {Biomedical Chromatography},
year = {2024},
doi = {10.1002/bmc.5998}
}
EUVIMED